Secondary Logo

Journal Logo

January/February 2022 - Volume 42 - Issue 1
pp: 1-113



Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors

Cosci, Fiammetta; Romanazzo, Sara; Mansueto, Giovanni; More

Journal of Clinical Psychopharmacology. 42(1):17-22, January/February 2022.

The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly: Clinical Pharmacokinetic Evaluation in Patients With Schizophrenia (Preliminary Data)

Mauri, Massimo Carlo; Franco, Gemma; Minutillo, Alessandro; More

Journal of Clinical Psychopharmacology. 42(1):23-30, January/February 2022.

Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia

Strømme, Maria F.; Mellesdal, Liv S.; Bartz-Johannesen, Christoffer A.; More

Journal of Clinical Psychopharmacology. 42(1):37-42, January/February 2022.



Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment

Garriga, Marina; Mallorquí, Andrea; Bernad, Sonia; More

Journal of Clinical Psychopharmacology. 42(1):75-80, January/February 2022.

Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy

Berger, Maximilian; Kermer, Josephine; Behr, Joachim; More

Journal of Clinical Psychopharmacology. 42(1):87-91, January/February 2022.



Show: